Dermaseptin DRS-CA-1

General Information


DRACP ID  DRACP03709

Peptide Name   Dermaseptin DRS-CA-1

Sequence  ALWKDLLKNVGKAAGKAVLNKVTDMVNQ

Sequence Length  28

UniProt ID  A0A345FZ91 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C135H230N38O38S

Absent amino acids  CEFHIPRSY

Common amino acids  K

Mass  350742

Pl  10.63

Basic residues  5

Acidic residues  2

Hydrophobic residues  13

Net charge  3

Boman Index  -2358

Hydrophobicity  -6.43

Aliphatic Index  111.43

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  203.7

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30258724

Title  Discovery of two skin-derived dermaseptins and design of a TAT-fusion analogue with broad-spectrum antimicrobial activity and low cytotoxicity on healthy cells

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  11804

DRACP is developed by Dr.Zheng's team.